301277.SZ
Newland Pharmaceutical Co., Ltd.
SZSE · C 制造业 · CN
CNY 10.23
−3.40%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 33.08x
- PEG TTM
- —
- Price / book
- 2.66x
- Price / sales
- 5.86x
- Price / cash flow
- 63.46x
Enterprise value
- Enterprise value
- CNY 3.7B
- EV / sales
- 5.68x
- EV / EBITDA
- 19.72x
- EV / EBIT
- 33.57x
- Market cap
- CNY 4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026